Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Mayo MJ, Vierling JM, Bowlus CL, Levy C, Hirschfield GM, Neff GW, Galambos MR, Gordon SC, Borg BB, Harrison SA, Thuluvath PJ, Goel A, Shiffman ML, Swain MG, Jones DEJ, Trivedi P, Kremer AE, Aspinall RJ, Sheridan DA, Dörffel Y, Yang K, Choi YJ, McWherter CA. Mayo MJ, et al. Among authors: jones dej. Aliment Pharmacol Ther. 2024 Jan;59(2):186-200. doi: 10.1111/apt.17755. Epub 2023 Oct 30. Aliment Pharmacol Ther. 2024. PMID: 37904314
Unmet clinical need in autoimmune liver diseases.
Dyson JK, Webb G, Hirschfield GM, Lohse A, Beuers U, Lindor K, Jones DE. Dyson JK, et al. J Hepatol. 2015 Jan;62(1):208-18. doi: 10.1016/j.jhep.2014.09.010. Epub 2014 Sep 16. J Hepatol. 2015. PMID: 25234946 Free article. Review.
Novel therapeutic targets in primary biliary cirrhosis.
Dyson JK, Hirschfield GM, Adams DH, Beuers U, Mann DA, Lindor KD, Jones DE. Dyson JK, et al. Nat Rev Gastroenterol Hepatol. 2015 Mar;12(3):147-58. doi: 10.1038/nrgastro.2015.12. Epub 2015 Feb 3. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25645973 Review.
Liver disease in the UK.
Hirschfield GM, Thain C, Walmsley M, Brownlee A, Jones DE. Hirschfield GM, et al. Lancet. 2015 Feb 7;385(9967):503. doi: 10.1016/S0140-6736(15)60192-1. Lancet. 2015. PMID: 25705835 No abstract available.
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, Griffiths L, Lim R, Trembling P, Williamson K, Wareham NJ, Aldersley M, Bathgate A, Burroughs AK, Heneghan MA, Neuberger JM, Thorburn D, Hirschfield GM, Cordell HJ, Alexander GJ, Jones DE, Sandford RN, Mells GF; UK-PBC Consortium. Carbone M, et al. Hepatology. 2016 Mar;63(3):930-50. doi: 10.1002/hep.28017. Epub 2015 Oct 20. Hepatology. 2016. PMID: 26223498 Free PMC article.
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R. Beuers U, et al. Hepatology. 2015 Nov;62(5):1620-2. doi: 10.1002/hep.28140. Epub 2015 Sep 15. Hepatology. 2015. PMID: 26372460 No abstract available.
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R. Beuers U, et al. Gut. 2015 Nov;64(11):1671-2. doi: 10.1136/gutjnl-2015-310593. Epub 2015 Sep 14. Gut. 2015. PMID: 26374822 No abstract available.
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R. Beuers U, et al. Gastroenterology. 2015 Nov;149(6):1627-9. doi: 10.1053/j.gastro.2015.08.031. Epub 2015 Sep 15. Gastroenterology. 2015. PMID: 26385706 Free article. No abstract available.
172 results